Agios Pharmaceuticals (AGIO) Change in Inventory (2018 - 2026)

Agios Pharmaceuticals (AGIO) has 8 years of Change in Inventory data on file, last reported at -$4.9 million in Q2 2026.

• Quarterly Change in Inventory fell 497.02% year-over-year to -$4.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$696000.0 (down 110.07% YoY) and the FY2025 annual result came in at $5.3 million, down 37.89% from the prior year.
• Change in Inventory retreated to -$4.9 million in Q2 2026, from $2.2 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $4.3 million in Q2 2023 to a low of -$4.9 million in Q2 2026.
• A 5-year average of $1.7 million and a median of $1.7 million in 2023 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2023 — Change in Inventory surged 172.83% — and 2026, when it tumbled 497.02%.
• Tracing AGIO's Change in Inventory over 5 years: stood at $3.3 million in 2022, then slumped by 45.66% to $1.8 million in 2023, then sank by 34.13% to $1.2 million in 2024, then decreased by 25.36% to $886000.0 in 2025, then slumped by 657.0% to -$4.9 million in 2026.
• The last three Change in Inventory figures came in at -$4.9 million (Q2 2026), $2.2 million (Q1 2026), and $886000.0 (Q4 2025), per Business Quant data.